论文部分内容阅读
中国科技大学与上海海员医院合作开发成功的JLX-1型激光量子血疗仪不久前通过了鉴定.该仪器采用对血液具有免疫激活和活化功能的低剂量、调制式He-Ne激光作为光源,辐照患者离体血液,并伴以高氧合处理,对治疗脑血管系统疾病、慢性阻塞性肺病、糖尿病等有明显的疗效,并可作为恶性肿瘤化疗、放疗的支持疗法,从而成为实施光量子疗法的一种新的有效手段,对光量子血疗法和激光医学的深入发展有积极意义.鉴定认为:该仪器的
The JLX-1 laser quantum blood therapy instrument successfully developed by the China University of Science and Technology and the Shanghai Seamen’s Hospital has passed the appraisal not long ago. The instrument uses a low-dose, modulated He-Ne laser with immune activation and activation function as a light source. Irradiating patients with isolated blood, accompanied by hyperoxic treatment, has obvious curative effect on the treatment of cerebrovascular diseases, chronic obstructive pulmonary disease, diabetes, etc., and can be used as a supportive therapy for chemotherapy and radiotherapy of malignant tumors, thus becoming an implementation of light quantum A new and effective method of therapy has positive implications for the development of photon-based blood therapies and laser medicine. It is identified as: